Total antioxidant capacity in eales' disease, uveitis & cataract

Indian Journal of Medical Research

Volumn 134, Issue 7, 2011, Pages 83-90

  Selvi, Radhakrishnan ^a   Angayarkanni, Narayanasamy ^a   Biswas, Jyotirmay ^a   Ramakrishnan, Sivaramakrishnan ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

Antioxidant; Cataract; Eales' disease; Oxidants; Uveitis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CATARACT; CONTROLLED STUDY; EALES DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; UVEITIS;

EID: 80054758473     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995; 9: 526-33.
2. Halliwell B. Antioxidants in hyuman health and disease. Annu Rev Nutr 1996; 16: 33-50.
3. Dasgupta A, Malhotra D, Levy H, Marcadis D, Blackwell W, Johnston D. Decreased total antioxidant capacity but normal lipid hydroperoxide concentrations in sera of critically ill patients. Life Sci 1997; 60: 335-40.
4. Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz, E, et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 1997; 20: 1589-93.
5. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54: 356-61.
6. Das T, Biswas J, Kumar A, Nagpal PN, Namperumalsamy P, Patnaik B, et al. Eales' disease. Indian J Ophthalmol 1994; 42: 3-18.
7. Angayarkanni N, Selvi R, Pukhraj R, Biswas J, Bhavesh SJ, Tombran-Tink J. Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales' disease. J Ocul Biol Dis Inform 2009; 2: 20-8.
8. Kimura SJ, Carriker FR, Hogen MJ. Retinal vasculitis with intra ocular hemorrhage. Classification and results of special studies. Arch Opthalmol 1956; 56: 361-7.
9. Bhooma V, Sulochana KN, Biswas J, Ramakrishnan S. Eales' disease: accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. Curr Eye Res 1997; 16: 91-5.
10. Sulochana KN, Biswas J, Ramakrishnan S. Eales' disease: increased oxidation and peroxidation products of membrane constitutents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous. Curr Eye Res 1999; 19: 254-9.
11. Rajesh M, Sulochana KN, Coral K, Punitham R, Biswas J, Babu K, et al. Determination of carbonyl groups content in plasma proteins as a useful marker to assess the impairment in antioxidant defense in patients with Eales' disease. Indian J Ophthalmol 2004; 52: 139-44.
12. Rajesh M, Sulochana KN, Punitham R, Biswas J, Lakshmi S, Ramakrishnan S. Involvement of oxidative and nitrosative stress in promoting retinal vasculitis in patients with Eales' disease. Clin Biochem 2003; 36: 377-85.
13. Rajesh M, Ramesh A, Ravi PE, Balakrishnamurthy P, Coral K, Punitham R, et al. Accumulation of 8-hydroxydeoxyguanosine and its relationship with antioxidant parameters in patients with Eales'disease: implications for antioxidant therapy. Curr Eye Res 2003; 27: 103-10.
14. Rajesh M, Sulochana KN, Ramakrishnan S, Biswas J, Manoharan PT. Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy. Curr Eye Res 2004; 28: 399-407.
15. Saxena S, Srivastava P, Kumar D, Khanna VK, Seth PK. Decreased platelet membrane fluidity in retinal periphlebitis in Eales' disease. Ocul Immunol Inflamm 2006; 14: 113-6.
16. Srivastava P, Saxena S, Khanna VK, Kumar D, Nath R, Seth PK. Raised platelet thiobarbituric acid-reacting substances in proliferative Eales' disease. Indian J Ophthalmol 2000; 48: 307-9.
17. Rao NA, Romero JL, Fernandez MA, Sevanian A, Marak GE Jr. Effect of iron chelation on severity of ocular inflammation in an animal model. Arch Ophthalmol 1986; 104: 1369-71.
18. Wu GS, Zhang J, Rao NA. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 1997; 38: 1333-9.
19. Varma SD, Hegde K, Henein M. Oxidative damage to mouse lens in culture. Protective effect of pyruvate. Biochim Biophys Acta 2003; 1621: 246-52.
20. Giblin FJ. Glutathione: a vital lens antioxidant. J Ocul Pharmacol Ther 2000; 16: 121-35.
21. Saxena S, Kumar D. A new staging system for idiopathic retinal periphlebitis. Eur J Ophthalmol 2004; 14: 236-9.
22. Ledwozyw A, Michalak J, Stepien A, Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids, and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986; 155: 275-83.
23. Baker H, Frank O. Determination of viltamin E. In: Baker H, Frank O, editors: Clinical vitaminology: methods and interpretation. New York: Wiley; 1968. p.172-6.
24. Carl A, Edward B, Tietz AR. Text book of clinical chemistry, 2nd ed. Pennsylvania: W.B. Saunders Co.; 1994; p. 1313-4.
25. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-26.
26. Selvi R, Angayarkanni N, Bharathselvi M, Sivaramakrishna R, Anisha T, Jyotirmoy B, et al. Increase in Fe3+/Fe2+ ratio and iron-induced oxidative stress in Eales disease and presence of ferrous iron in circulating transferrin. Curr Eye Res 2007; 32: 677-83.
27. Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischaemic stroke. QJM 2002; 95: 685-90.
28. Thorat VN, Suryakar AN, Naik P, Tiwale BM. Total antioxidant capacity and lipid peroxidation in liver transplantation. Indian J Clin Biochem 2009; 24: 102-4.
29. Suresh DR, Annam V, Pratibha K, Prasad BV. Total antioxidant capacity - a novel early bio-chemical marker of oxidative stress in HIV infected individuals. J Biomed Sci 2009; 16: 61-4.
30. Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, et al. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 2006; 10: R36.
31. Zarban A, Taheri F, Chahkandi T, Sharifzadeh G, Khorashadizadeh M. Antioxidant and radical scavenging activity of human colostrum, transitional and mature milk. J Clin Biochem Nutr 2009; 45: 150-4.
32. Angayarkanni N, Barathi S, Seethalakshmi T, Punitham R, Sivaramakrishna R, Suganeswari G, et al. Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients. Eye (Lond) 2008; 22: 969-74.
33. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004; 137: 62-9.